Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000474221 | SCV000558156 | likely benign | Hypertrophic cardiomyopathy | 2024-12-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000617506 | SCV000740138 | likely benign | Cardiovascular phenotype | 2017-03-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001653843 | SCV001861864 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001798847 | SCV002042227 | likely benign | Cardiomyopathy | 2020-06-08 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330705 | SCV004038001 | likely benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000474221 | SCV004821503 | likely benign | Hypertrophic cardiomyopathy | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001798847 | SCV006061548 | likely benign | Cardiomyopathy | 2022-11-06 | criteria provided, single submitter | clinical testing |